Grey Innovation is delighted to introduce Matt McNamara as our newest member of the Board. Matt is passionate about commercialising exciting new healthcare technologies that will make a difference to people’s lives all over the world.
Previously Matt was Chief Investment Officer at BioScience Managers (2005-2019), responsible for deal flow management and evaluation, leading all investment recommendations and due diligence.
Matt has over 30 years’ experience in the healthcare & medical sciences sector. He founded BioBridge Australia, a biotechnology commercialisation advisory company, in 2003 and advised a number of private and public biotechnology/investment companies. He has served as SVP Business Development for eBioinformatics Inc and was CEO of SciCapital Pty Ltd, a Life Sciences Venture Capital fund.
Previously, Matt spent over a decade in the pharma industry working in Sales & Marketing with Merck & Co. and in General Management at Johnson and Johnson Medical Pty Ltd.
Matt received his BSc in Molecular Biology from La Trobe University, Melbourne, Australia and was a research assistant at this University during 1987. He completed his MBA at the University of Sydney. Matt completed the Australian Company Directors Course in 2014.
Matt is currently a Director of Adherium Limited ((ASX; ADR)